

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GMP metabolic process (GO:0046037) | 9.76486657 |
| 2 | regulation of guanylate cyclase activity (GO:0031282) | 9.52395516 |
| 3 | protein-chromophore linkage (GO:0018298) | 9.07003132 |
| 4 | retinal rod cell development (GO:0046548) | 9.06373606 |
| 5 | visual perception (GO:0007601) | 8.74427917 |
| 6 | sensory perception of light stimulus (GO:0050953) | 8.65277938 |
| 7 | cellular response to light stimulus (GO:0071482) | 7.54900950 |
| 8 | photoreceptor cell differentiation (GO:0046530) | 7.49141240 |
| 9 | eye photoreceptor cell differentiation (GO:0001754) | 7.49141240 |
| 10 | detection of external stimulus (GO:0009581) | 7.03576058 |
| 11 | detection of abiotic stimulus (GO:0009582) | 6.92025520 |
| 12 | regulation of cGMP metabolic process (GO:0030823) | 6.73350936 |
| 13 | retina development in camera-type eye (GO:0060041) | 6.51111772 |
| 14 | positive regulation of cGMP biosynthetic process (GO:0030828) | 6.20022269 |
| 15 | regulation of cGMP biosynthetic process (GO:0030826) | 5.84557528 |
| 16 | positive regulation of cGMP metabolic process (GO:0030825) | 5.50060274 |
| 17 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.45465451 |
| 18 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 5.30098722 |
| 19 | nonmotile primary cilium assembly (GO:0035058) | 5.25123043 |
| 20 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 5.14923109 |
| 21 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 5.14727549 |
| 22 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 5.07665608 |
| 23 | cellular response to radiation (GO:0071478) | 4.98307993 |
| 24 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.71334615 |
| 25 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.52335952 |
| 26 | regulation of G-protein coupled receptor protein signaling pathway (GO:0008277) | 4.51991558 |
| 27 | nucleobase catabolic process (GO:0046113) | 4.48204971 |
| 28 | adaptation of signaling pathway (GO:0023058) | 4.48170296 |
| 29 | behavioral response to nicotine (GO:0035095) | 4.32560245 |
| 30 | sensory perception (GO:0007600) | 4.19414420 |
| 31 | response to pheromone (GO:0019236) | 4.15829850 |
| 32 | regulation of cilium movement (GO:0003352) | 4.06989928 |
| 33 | regulation of penile erection (GO:0060405) | 4.02757939 |
| 34 | protein prenylation (GO:0018342) | 4.00372647 |
| 35 | prenylation (GO:0097354) | 4.00372647 |
| 36 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.99626911 |
| 37 | estrogen biosynthetic process (GO:0006703) | 3.96896724 |
| 38 | epithelial cilium movement (GO:0003351) | 3.94599901 |
| 39 | NADH dehydrogenase complex assembly (GO:0010257) | 3.88065937 |
| 40 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.88065937 |
| 41 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.88065937 |
| 42 | response to light stimulus (GO:0009416) | 3.87503144 |
| 43 | protein complex biogenesis (GO:0070271) | 3.86528623 |
| 44 | ubiquinone biosynthetic process (GO:0006744) | 3.83338175 |
| 45 | protein polyglutamylation (GO:0018095) | 3.80464313 |
| 46 | neuron development (GO:0048666) | 3.72359358 |
| 47 | short-term memory (GO:0007614) | 3.69735655 |
| 48 | positive regulation of mitochondrial fission (GO:0090141) | 3.67874446 |
| 49 | behavioral response to ethanol (GO:0048149) | 3.65632285 |
| 50 | retina layer formation (GO:0010842) | 3.59773129 |
| 51 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.58364792 |
| 52 | retina homeostasis (GO:0001895) | 3.57919941 |
| 53 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.56889868 |
| 54 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.56889868 |
| 55 | neural tube formation (GO:0001841) | 3.55432458 |
| 56 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.52532040 |
| 57 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.52188004 |
| 58 | ubiquinone metabolic process (GO:0006743) | 3.49331304 |
| 59 | platelet dense granule organization (GO:0060155) | 3.45325584 |
| 60 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.31839755 |
| 61 | DNA deamination (GO:0045006) | 3.30438171 |
| 62 | replication fork processing (GO:0031297) | 3.28128597 |
| 63 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.27903160 |
| 64 | response to histamine (GO:0034776) | 3.27082176 |
| 65 | chemosensory behavior (GO:0007635) | 3.22627087 |
| 66 | postsynaptic membrane organization (GO:0001941) | 3.20806997 |
| 67 | respiratory chain complex IV assembly (GO:0008535) | 3.19855013 |
| 68 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.18041841 |
| 69 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 3.17567816 |
| 70 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 3.15426043 |
| 71 | peptidyl-histidine modification (GO:0018202) | 3.14483061 |
| 72 | positive regulation of neurotransmitter transport (GO:0051590) | 3.13539159 |
| 73 | quinone biosynthetic process (GO:1901663) | 3.13215260 |
| 74 | mannosylation (GO:0097502) | 3.12872690 |
| 75 | piRNA metabolic process (GO:0034587) | 3.12372150 |
| 76 | arginine catabolic process (GO:0006527) | 3.11845647 |
| 77 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 3.05999391 |
| 78 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.03862752 |
| 79 | synaptic transmission, cholinergic (GO:0007271) | 3.01810829 |
| 80 | cilium movement (GO:0003341) | 3.01454064 |
| 81 | protein heterotetramerization (GO:0051290) | 3.01343344 |
| 82 | resolution of meiotic recombination intermediates (GO:0000712) | 3.01066365 |
| 83 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.99350743 |
| 84 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 2.98224666 |
| 85 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.96990746 |
| 86 | tachykinin receptor signaling pathway (GO:0007217) | 2.95151333 |
| 87 | cornea development in camera-type eye (GO:0061303) | 2.94737042 |
| 88 | cytochrome complex assembly (GO:0017004) | 2.94426441 |
| 89 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 2.93730283 |
| 90 | regulation of microtubule-based movement (GO:0060632) | 2.93021747 |
| 91 | protein localization to cilium (GO:0061512) | 2.91764271 |
| 92 | regulation of hexokinase activity (GO:1903299) | 2.90573893 |
| 93 | regulation of glucokinase activity (GO:0033131) | 2.90573893 |
| 94 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 2.90486849 |
| 95 | protein localization to synapse (GO:0035418) | 2.87058391 |
| 96 | negative regulation of telomere maintenance (GO:0032205) | 2.86478788 |
| 97 | cilium morphogenesis (GO:0060271) | 2.85553997 |
| 98 | fucose catabolic process (GO:0019317) | 2.83709476 |
| 99 | L-fucose metabolic process (GO:0042354) | 2.83709476 |
| 100 | L-fucose catabolic process (GO:0042355) | 2.83709476 |
| 101 | quinone metabolic process (GO:1901661) | 2.82637865 |
| 102 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.82457701 |
| 103 | establishment of mitochondrion localization (GO:0051654) | 2.80448884 |
| 104 | presynaptic membrane assembly (GO:0097105) | 2.79529355 |
| 105 | membrane hyperpolarization (GO:0060081) | 2.79062229 |
| 106 | nucleotide transmembrane transport (GO:1901679) | 2.78975314 |
| 107 | regulation of meiosis I (GO:0060631) | 2.77717562 |
| 108 | axoneme assembly (GO:0035082) | 2.75440972 |
| 109 | response to radiation (GO:0009314) | 2.74197421 |
| 110 | dopamine transport (GO:0015872) | 2.74148385 |
| 111 | retinoid metabolic process (GO:0001523) | 2.73862569 |
| 112 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.72388071 |
| 113 | retinol metabolic process (GO:0042572) | 2.72381931 |
| 114 | gamma-aminobutyric acid transport (GO:0015812) | 2.72345440 |
| 115 | anterograde synaptic vesicle transport (GO:0048490) | 2.70769474 |
| 116 | positive regulation of ERBB signaling pathway (GO:1901186) | 2.70721006 |
| 117 | cellular ketone body metabolic process (GO:0046950) | 2.68961178 |
| 118 | kidney morphogenesis (GO:0060993) | 2.65952307 |
| 119 | regulation of mitochondrial fission (GO:0090140) | 2.65350769 |
| 120 | arachidonic acid secretion (GO:0050482) | 2.64839531 |
| 121 | icosanoid secretion (GO:0032309) | 2.64839531 |
| 122 | S-adenosylmethionine metabolic process (GO:0046500) | 2.63440872 |
| 123 | synaptic transmission, dopaminergic (GO:0001963) | 2.61812336 |
| 124 | amine catabolic process (GO:0009310) | 2.60538412 |
| 125 | cellular biogenic amine catabolic process (GO:0042402) | 2.60538412 |
| 126 | neuron cell-cell adhesion (GO:0007158) | 2.59348786 |
| 127 | tRNA processing (GO:0008033) | 2.58002017 |
| 128 | negative regulation of cation channel activity (GO:2001258) | 2.57196729 |
| 129 | maturation of 5.8S rRNA (GO:0000460) | 2.57039633 |
| 130 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.54875569 |
| 131 | ketone body metabolic process (GO:1902224) | 2.53977873 |
| 132 | aldehyde catabolic process (GO:0046185) | 2.53676153 |
| 133 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.53507357 |
| 134 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.53507357 |
| 135 | behavioral response to cocaine (GO:0048148) | 2.52967177 |
| 136 | GPI anchor metabolic process (GO:0006505) | 2.52663118 |
| 137 | dopamine receptor signaling pathway (GO:0007212) | 2.52580268 |
| 138 | diterpenoid metabolic process (GO:0016101) | 2.51738107 |
| 139 | cellular response to abiotic stimulus (GO:0071214) | 2.50903321 |
| 140 | inositol phosphate catabolic process (GO:0071545) | 2.50133354 |
| 141 | regulation of action potential (GO:0098900) | 2.49511524 |
| 142 | positive regulation of cyclase activity (GO:0031281) | 2.49371511 |
| 143 | kynurenine metabolic process (GO:0070189) | 2.49093921 |
| 144 | branched-chain amino acid catabolic process (GO:0009083) | 2.48336021 |
| 145 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.45722606 |
| 146 | DNA integration (GO:0015074) | 2.44016460 |
| 147 | short-chain fatty acid metabolic process (GO:0046459) | 2.43195240 |
| 148 | regulation of neurotransmitter uptake (GO:0051580) | 2.41503886 |
| 149 | peroxisome fission (GO:0016559) | 2.41221402 |
| 150 | regulation of feeding behavior (GO:0060259) | 2.40357711 |
| 151 | cilium organization (GO:0044782) | 2.39693381 |
| 152 | presynaptic membrane organization (GO:0097090) | 2.39187365 |
| 153 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.38962933 |
| 154 | neurotransmitter catabolic process (GO:0042135) | 2.38605612 |
| 155 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.38221431 |
| 156 | negative regulation of mast cell activation (GO:0033004) | 2.36178769 |
| 157 | intraciliary transport (GO:0042073) | 2.35322806 |
| 158 | calcium ion-dependent exocytosis (GO:0017156) | 2.35289760 |
| 159 | C-terminal protein lipidation (GO:0006501) | 2.35225000 |
| 160 | cilium assembly (GO:0042384) | 2.35164089 |
| 161 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.34505689 |
| 162 | termination of RNA polymerase III transcription (GO:0006386) | 2.34505689 |
| 163 | phospholipid translocation (GO:0045332) | 2.33990932 |
| 164 | lipid translocation (GO:0034204) | 2.33990932 |
| 165 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.32870745 |
| 166 | positive regulation of lyase activity (GO:0051349) | 2.32493875 |
| 167 | post-embryonic morphogenesis (GO:0009886) | 2.32136009 |
| 168 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.30906121 |
| 169 | terpenoid metabolic process (GO:0006721) | 2.29656523 |
| 170 | regulation of catecholamine metabolic process (GO:0042069) | 2.28546396 |
| 171 | regulation of dopamine metabolic process (GO:0042053) | 2.28546396 |
| 172 | startle response (GO:0001964) | 2.23697565 |
| 173 | sensory perception of smell (GO:0007608) | 2.20603409 |
| 174 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 18.8049026 |
| 175 | rhodopsin mediated signaling pathway (GO:0016056) | 18.1780138 |
| 176 | retinal cone cell development (GO:0046549) | 16.1717162 |
| 177 | photoreceptor cell development (GO:0042461) | 12.3955023 |
| 178 | eye photoreceptor cell development (GO:0042462) | 11.9429138 |
| 179 | detection of light stimulus involved in sensory perception (GO:0050962) | 10.9665243 |
| 180 | detection of light stimulus involved in visual perception (GO:0050908) | 10.9665243 |
| 181 | * photoreceptor cell maintenance (GO:0045494) | 10.9601644 |
| 182 | phototransduction (GO:0007602) | 10.6666983 |
| 183 | phototransduction, visible light (GO:0007603) | 10.5113033 |
| 184 | positive regulation of guanylate cyclase activity (GO:0031284) | 10.4946937 |
| 185 | detection of light stimulus (GO:0009583) | 10.0996198 |
| 186 | detection of visible light (GO:0009584) | 10.0239102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.96470773 |
| 2 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.99454560 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 3.78707118 |
| 4 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 3.75191491 |
| 5 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.66478802 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.42017841 |
| 7 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.23272397 |
| 8 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.60052447 |
| 9 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.48605425 |
| 10 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.29771006 |
| 11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.26054224 |
| 12 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.18966181 |
| 13 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.15726689 |
| 14 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.12897479 |
| 15 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.12839652 |
| 16 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.10706153 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.01623342 |
| 18 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.00928197 |
| 19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.95660457 |
| 20 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.83414860 |
| 21 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.82881437 |
| 22 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.77100059 |
| 23 | FUS_26573619_Chip-Seq_HEK293_Human | 1.73860478 |
| 24 | EWS_26573619_Chip-Seq_HEK293_Human | 1.73325629 |
| 25 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.68543490 |
| 26 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.67715989 |
| 27 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.67715989 |
| 28 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.67600684 |
| 29 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.67446645 |
| 30 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.66488304 |
| 31 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.66304937 |
| 32 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.65763113 |
| 33 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.61788397 |
| 34 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.59864316 |
| 35 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.58038519 |
| 36 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.56701931 |
| 37 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.56176786 |
| 38 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.54279178 |
| 39 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.53785525 |
| 40 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.50255775 |
| 41 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.49992567 |
| 42 | P300_19829295_ChIP-Seq_ESCs_Human | 1.48691947 |
| 43 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.48271262 |
| 44 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.47832675 |
| 45 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.47323899 |
| 46 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.47311666 |
| 47 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.43911047 |
| 48 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.41472929 |
| 49 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.40340964 |
| 50 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.39165046 |
| 51 | AR_19668381_ChIP-Seq_PC3_Human | 1.37880591 |
| 52 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.37456258 |
| 53 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.37230151 |
| 54 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.34799030 |
| 55 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.34620119 |
| 56 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.34469678 |
| 57 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.34131315 |
| 58 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.33303894 |
| 59 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.32543186 |
| 60 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32067293 |
| 61 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.31960306 |
| 62 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.31959444 |
| 63 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.31805582 |
| 64 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.31773635 |
| 65 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.31126491 |
| 66 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.30110660 |
| 67 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.29675975 |
| 68 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.29330719 |
| 69 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.29144312 |
| 70 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.29144312 |
| 71 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.28669524 |
| 72 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.27772329 |
| 73 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.27772329 |
| 74 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.27187611 |
| 75 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.26580593 |
| 76 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.26355154 |
| 77 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.25877647 |
| 78 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.25262362 |
| 79 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.25104147 |
| 80 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.25041400 |
| 81 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.24257907 |
| 82 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.23836745 |
| 83 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.23584268 |
| 84 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23553897 |
| 85 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.22167380 |
| 86 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.21798827 |
| 87 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.21208340 |
| 88 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.21098242 |
| 89 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.19826117 |
| 90 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.18906381 |
| 91 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.18906381 |
| 92 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.18879046 |
| 93 | AR_25329375_ChIP-Seq_VCAP_Human | 1.18841701 |
| 94 | TBL1_22424771_ChIP-Seq_293T_Human | 1.18055472 |
| 95 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.17279443 |
| 96 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.16819130 |
| 97 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.16024656 |
| 98 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.15028665 |
| 99 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.11168217 |
| 100 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.10956052 |
| 101 | TCF4_23295773_ChIP-Seq_U87_Human | 1.09522599 |
| 102 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09378001 |
| 103 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.09109357 |
| 104 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.08678513 |
| 105 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.08651780 |
| 106 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.08447144 |
| 107 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.07366715 |
| 108 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.06980099 |
| 109 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06822763 |
| 110 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.06633704 |
| 111 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06546727 |
| 112 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.06470841 |
| 113 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06440306 |
| 114 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.05841576 |
| 115 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05826929 |
| 116 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.05826929 |
| 117 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.05818118 |
| 118 | AR_20517297_ChIP-Seq_VCAP_Human | 1.05734925 |
| 119 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.05242172 |
| 120 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.05206638 |
| 121 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.05200252 |
| 122 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.03199428 |
| 123 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.02983283 |
| 124 | ERA_21632823_ChIP-Seq_H3396_Human | 1.02652500 |
| 125 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.02514366 |
| 126 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.02032411 |
| 127 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02021201 |
| 128 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.01878200 |
| 129 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.01455966 |
| 130 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.01431738 |
| 131 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01324202 |
| 132 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.00314937 |
| 133 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.99483177 |
| 134 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.99205200 |
| 135 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.98283997 |
| 136 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.98183672 |
| 137 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.97225094 |
| 138 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.96023620 |
| 139 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.95729203 |
| 140 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.95591193 |
| 141 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.94945228 |
| 142 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.94510529 |
| 143 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.94456202 |
| 144 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.93988584 |
| 145 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.93897072 |
| 146 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.93698347 |
| 147 | NCOR_22424771_ChIP-Seq_293T_Human | 0.93304663 |
| 148 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93146936 |
| 149 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.93140371 |
| 150 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.92917392 |
| 151 | KDM2B_26808549_Chip-Seq_REH_Human | 0.92204111 |
| 152 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.91975568 |
| 153 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.91323632 |
| 154 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.91208909 |
| 155 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.91207958 |
| 156 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.91152373 |
| 157 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.90911465 |
| 158 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.89768425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005551_abnormal_eye_electrophysiolog | 9.86481636 |
| 2 | MP0005253_abnormal_eye_physiology | 6.97603269 |
| 3 | MP0006072_abnormal_retinal_apoptosis | 6.30090184 |
| 4 | MP0003950_abnormal_plasma_membrane | 4.04371939 |
| 5 | MP0005195_abnormal_posterior_eye | 3.88919437 |
| 6 | MP0003787_abnormal_imprinting | 3.62731855 |
| 7 | MP0001324_abnormal_eye_pigmentation | 3.55404713 |
| 8 | MP0005391_vision/eye_phenotype | 3.41206050 |
| 9 | MP0002638_abnormal_pupillary_reflex | 3.28572646 |
| 10 | MP0001986_abnormal_taste_sensitivity | 2.83113659 |
| 11 | MP0003195_calcinosis | 2.82708065 |
| 12 | MP0008877_abnormal_DNA_methylation | 2.81073975 |
| 13 | MP0002090_abnormal_vision | 2.76092453 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.65746872 |
| 15 | MP0001529_abnormal_vocalization | 2.61979733 |
| 16 | MP0002837_dystrophic_cardiac_calcinosis | 2.53575560 |
| 17 | MP0002229_neurodegeneration | 2.50192249 |
| 18 | MP0001764_abnormal_homeostasis | 2.27030777 |
| 19 | MP0008875_abnormal_xenobiotic_pharmacok | 2.26295501 |
| 20 | MP0003011_delayed_dark_adaptation | 10.6207584 |
| 21 | MP0002752_abnormal_somatic_nervous | 1.95199890 |
| 22 | MP0000372_irregular_coat_pigmentation | 1.94084713 |
| 23 | MP0004133_heterotaxia | 1.81590714 |
| 24 | MP0008872_abnormal_physiological_respon | 1.74953907 |
| 25 | MP0003121_genomic_imprinting | 1.72092715 |
| 26 | MP0002736_abnormal_nociception_after | 1.70183925 |
| 27 | MP0006276_abnormal_autonomic_nervous | 1.66742838 |
| 28 | MP0002234_abnormal_pharynx_morphology | 1.66422406 |
| 29 | MP0001485_abnormal_pinna_reflex | 1.64874787 |
| 30 | MP0003122_maternal_imprinting | 1.60123818 |
| 31 | MP0004147_increased_porphyrin_level | 1.42502494 |
| 32 | MP0003283_abnormal_digestive_organ | 1.41965704 |
| 33 | MP0003252_abnormal_bile_duct | 1.40177426 |
| 34 | MP0006292_abnormal_olfactory_placode | 1.36940628 |
| 35 | MP0002882_abnormal_neuron_morphology | 1.35739590 |
| 36 | MP0008995_early_reproductive_senescence | 1.34471312 |
| 37 | MP0003186_abnormal_redox_activity | 1.31014778 |
| 38 | MP0004019_abnormal_vitamin_homeostasis | 1.28915258 |
| 39 | MP0005084_abnormal_gallbladder_morpholo | 1.26314627 |
| 40 | MP0001270_distended_abdomen | 1.26009576 |
| 41 | MP0002653_abnormal_ependyma_morphology | 1.23986795 |
| 42 | MP0001984_abnormal_olfaction | 1.21164857 |
| 43 | MP0001502_abnormal_circadian_rhythm | 1.20969591 |
| 44 | MP0002938_white_spotting | 1.18640998 |
| 45 | MP0002735_abnormal_chemical_nociception | 1.15418934 |
| 46 | MP0005410_abnormal_fertilization | 1.09404305 |
| 47 | MP0003718_maternal_effect | 1.08535264 |
| 48 | MP0001970_abnormal_pain_threshold | 1.08230001 |
| 49 | MP0005394_taste/olfaction_phenotype | 1.05919855 |
| 50 | MP0005499_abnormal_olfactory_system | 1.05919855 |
| 51 | MP0008789_abnormal_olfactory_epithelium | 1.04766937 |
| 52 | MP0002733_abnormal_thermal_nociception | 1.03102934 |
| 53 | MP0005197_abnormal_uvea_morphology | 1.02788377 |
| 54 | MP0006035_abnormal_mitochondrial_morpho | 1.02492992 |
| 55 | MP0002163_abnormal_gland_morphology | 1.01460765 |
| 56 | MP0004885_abnormal_endolymph | 1.00321853 |
| 57 | MP0002254_reproductive_system_inflammat | 0.95469686 |
| 58 | MP0003136_yellow_coat_color | 0.94143454 |
| 59 | MP0008775_abnormal_heart_ventricle | 0.94015329 |
| 60 | MP0006036_abnormal_mitochondrial_physio | 0.91535399 |
| 61 | MP0002127_abnormal_cardiovascular_syste | 0.87768390 |
| 62 | MP0002909_abnormal_adrenal_gland | 0.87330754 |
| 63 | MP0002332_abnormal_exercise_endurance | 0.87007398 |
| 64 | MP0003137_abnormal_impulse_conducting | 0.86943952 |
| 65 | MP0000427_abnormal_hair_cycle | 0.85759810 |
| 66 | MP0001486_abnormal_startle_reflex | 0.83479868 |
| 67 | MP0002095_abnormal_skin_pigmentation | 0.83236234 |
| 68 | MP0002822_catalepsy | 0.81665794 |
| 69 | MP0001919_abnormal_reproductive_system | 0.79388102 |
| 70 | MP0004233_abnormal_muscle_weight | 0.77821990 |
| 71 | MP0003634_abnormal_glial_cell | 0.75679724 |
| 72 | MP0005646_abnormal_pituitary_gland | 0.73990525 |
| 73 | MP0002751_abnormal_autonomic_nervous | 0.73551110 |
| 74 | MP0003698_abnormal_male_reproductive | 0.72860066 |
| 75 | MP0005389_reproductive_system_phenotype | 0.72674873 |
| 76 | MP0002069_abnormal_eating/drinking_beha | 0.71436811 |
| 77 | MP0005332_abnormal_amino_acid | 0.71284829 |
| 78 | MP0002272_abnormal_nervous_system | 0.70832777 |
| 79 | MP0001963_abnormal_hearing_physiology | 0.64637810 |
| 80 | MP0001286_abnormal_eye_development | 0.61989978 |
| 81 | MP0004782_abnormal_surfactant_physiolog | 0.57642288 |
| 82 | MP0004270_analgesia | 0.55268070 |
| 83 | MP0005187_abnormal_penis_morphology | 0.54109137 |
| 84 | MP0010386_abnormal_urinary_bladder | 0.51016815 |
| 85 | MP0002734_abnormal_mechanical_nocicepti | 0.48807940 |
| 86 | MP0000026_abnormal_inner_ear | 0.47652223 |
| 87 | MP0005376_homeostasis/metabolism_phenot | 0.45376224 |
| 88 | MP0003045_fibrosis | 0.44171651 |
| 89 | MP0002572_abnormal_emotion/affect_behav | 0.43625174 |
| 90 | MP0001905_abnormal_dopamine_level | 0.43262756 |
| 91 | MP0009046_muscle_twitch | 0.42991013 |
| 92 | MP0001188_hyperpigmentation | 0.42770844 |
| 93 | MP0002067_abnormal_sensory_capabilities | 0.42475694 |
| 94 | MP0000631_abnormal_neuroendocrine_gland | 0.41116506 |
| 95 | MP0002064_seizures | 0.40964062 |
| 96 | MP0002102_abnormal_ear_morphology | 0.40784624 |
| 97 | MP0004742_abnormal_vestibular_system | 0.39135057 |
| 98 | MP0000465_gastrointestinal_hemorrhage | 0.37464133 |
| 99 | MP0002063_abnormal_learning/memory/cond | 0.37079772 |
| 100 | MP0000569_abnormal_digit_pigmentation | 0.36616193 |
| 101 | MP0003880_abnormal_central_pattern | 0.36553026 |
| 102 | MP0008058_abnormal_DNA_repair | 0.36428534 |
| 103 | MP0004142_abnormal_muscle_tone | 0.34321845 |
| 104 | MP0005386_behavior/neurological_phenoty | 0.33165077 |
| 105 | MP0004924_abnormal_behavior | 0.33165077 |
| 106 | MP0003635_abnormal_synaptic_transmissio | 0.31971143 |
| 107 | MP0009745_abnormal_behavioral_response | 0.31681571 |
| 108 | MP0009780_abnormal_chondrocyte_physiolo | 0.30361117 |
| 109 | MP0004043_abnormal_pH_regulation | 0.29623527 |
| 110 | MP0004215_abnormal_myocardial_fiber | 0.29495029 |
| 111 | MP0005310_abnormal_salivary_gland | 0.28782756 |
| 112 | MP0005595_abnormal_vascular_smooth | 0.28746386 |
| 113 | MP0002928_abnormal_bile_duct | 0.27212797 |
| 114 | MP0001968_abnormal_touch/_nociception | 0.26333172 |
| 115 | MP0005620_abnormal_muscle_contractility | 0.25203351 |
| 116 | MP0004145_abnormal_muscle_electrophysio | 0.24107294 |
| 117 | MP0001177_atelectasis | 0.23937725 |
| 118 | MP0004085_abnormal_heartbeat | 0.23813509 |
| 119 | MP0008004_abnormal_stomach_pH | 0.22125958 |
| 120 | MP0005248_abnormal_Harderian_gland | 0.21935272 |
| 121 | MP0003943_abnormal_hepatobiliary_system | 0.20680044 |
| 122 | MP0002557_abnormal_social/conspecific_i | 0.20399376 |
| 123 | MP0000778_abnormal_nervous_system | 0.18473133 |
| 124 | MP0002152_abnormal_brain_morphology | 0.18400281 |
| 125 | MP0008569_lethality_at_weaning | 0.17679710 |
| 126 | MP0001661_extended_life_span | 0.17391217 |
| 127 | MP0003890_abnormal_embryonic-extraembry | 0.16711659 |
| 128 | MP0002876_abnormal_thyroid_physiology | 0.16065273 |
| 129 | MP0003646_muscle_fatigue | 0.16001662 |
| 130 | MP0004859_abnormal_synaptic_plasticity | 0.15634035 |
| 131 | MP0002066_abnormal_motor_capabilities/c | 0.15583817 |
| 132 | MP0002697_abnormal_eye_size | 0.15170572 |
| 133 | MP0010030_abnormal_orbit_morphology | 0.14259248 |
| 134 | MP0001915_intracranial_hemorrhage | 0.13675646 |
| 135 | MP0005193_abnormal_anterior_eye | 0.13595755 |
| 136 | MP0004811_abnormal_neuron_physiology | 0.13174600 |
| 137 | MP0002108_abnormal_muscle_morphology | 0.13104700 |
| 138 | MP0002184_abnormal_innervation | 0.12754475 |
| 139 | MP0005645_abnormal_hypothalamus_physiol | 0.12037110 |
| 140 | MP0001501_abnormal_sleep_pattern | 0.11638777 |
| 141 | MP0003638_abnormal_response/metabolism_ | 0.11082454 |
| 142 | MP0003632_abnormal_nervous_system | 0.10188600 |
| 143 | MP0001293_anophthalmia | 0.10007756 |
| 144 | MP0009764_decreased_sensitivity_to | 0.09955134 |
| 145 | MP0003183_abnormal_peptide_metabolism | 0.09877105 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pigmentary retinal degeneration (HP:0001146) | 9.55373573 |
| 2 | Chorioretinal atrophy (HP:0000533) | 8.76434241 |
| 3 | Dyschromatopsia (HP:0007641) | 8.39523874 |
| 4 | Attenuation of retinal blood vessels (HP:0007843) | 7.86437266 |
| 5 | Central scotoma (HP:0000603) | 7.84339120 |
| 6 | Pendular nystagmus (HP:0012043) | 7.51533417 |
| 7 | Abnormality of macular pigmentation (HP:0008002) | 7.46225637 |
| 8 | Scotoma (HP:0000575) | 7.07515765 |
| 9 | Abolished electroretinogram (ERG) (HP:0000550) | 6.40509188 |
| 10 | Decreased central vision (HP:0007663) | 6.15402504 |
| 11 | Photophobia (HP:0000613) | 5.85234980 |
| 12 | Type II diabetes mellitus (HP:0005978) | 5.80233335 |
| 13 | Vitreoretinal degeneration (HP:0000655) | 5.04479784 |
| 14 | Macular degeneration (HP:0000608) | 4.85301000 |
| 15 | Keratoconus (HP:0000563) | 4.85180375 |
| 16 | Increased corneal curvature (HP:0100692) | 4.85180375 |
| 17 | Cone-rod dystrophy (HP:0000548) | 4.61599212 |
| 18 | Retinitis pigmentosa (HP:0000510) | 4.58459470 |
| 19 | Choroideremia (HP:0001139) | 4.51989072 |
| 20 | Posterior subcapsular cataract (HP:0007787) | 4.38216152 |
| 21 | Severe visual impairment (HP:0001141) | 4.35231376 |
| 22 | Constricted visual fields (HP:0001133) | 4.28219652 |
| 23 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.59506788 |
| 24 | Abnormality of the renal cortex (HP:0011035) | 3.29128913 |
| 25 | Intestinal atresia (HP:0011100) | 3.21640590 |
| 26 | Progressive visual loss (HP:0000529) | 3.09794410 |
| 27 | Acute necrotizing encephalopathy (HP:0006965) | 2.98538233 |
| 28 | Type II lissencephaly (HP:0007260) | 2.95528176 |
| 29 | Renal cortical cysts (HP:0000803) | 2.88868040 |
| 30 | Retinal atrophy (HP:0001105) | 2.84390639 |
| 31 | Hepatocellular necrosis (HP:0001404) | 2.83587399 |
| 32 | Optic disc pallor (HP:0000543) | 2.78307599 |
| 33 | Acute encephalopathy (HP:0006846) | 2.75313945 |
| 34 | Lissencephaly (HP:0001339) | 2.75242129 |
| 35 | Congenital sensorineural hearing impairment (HP:0008527) | 2.74614946 |
| 36 | Hyperglycinemia (HP:0002154) | 2.73839759 |
| 37 | Congenital primary aphakia (HP:0007707) | 2.71864884 |
| 38 | Gait imbalance (HP:0002141) | 2.71758379 |
| 39 | Increased CSF lactate (HP:0002490) | 2.71737283 |
| 40 | Progressive macrocephaly (HP:0004481) | 2.71176903 |
| 41 | Mitochondrial inheritance (HP:0001427) | 2.69541454 |
| 42 | Subcapsular cataract (HP:0000523) | 2.66805172 |
| 43 | Progressive inability to walk (HP:0002505) | 2.66399923 |
| 44 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.65389572 |
| 45 | Wide nasal bridge (HP:0000431) | 2.60518870 |
| 46 | Hepatic necrosis (HP:0002605) | 2.53116147 |
| 47 | Inability to walk (HP:0002540) | 2.48147040 |
| 48 | Nephrogenic diabetes insipidus (HP:0009806) | 2.47173634 |
| 49 | Medial flaring of the eyebrow (HP:0010747) | 2.43171107 |
| 50 | Absent speech (HP:0001344) | 2.35123677 |
| 51 | Hyperglycinuria (HP:0003108) | 2.34769909 |
| 52 | Hyperventilation (HP:0002883) | 2.32289507 |
| 53 | Large for gestational age (HP:0001520) | 2.32040218 |
| 54 | Pachygyria (HP:0001302) | 2.31772925 |
| 55 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.31459138 |
| 56 | Abnormality of the labia minora (HP:0012880) | 2.25936607 |
| 57 | Thyroid-stimulating hormone excess (HP:0002925) | 2.25190004 |
| 58 | Abnormal drinking behavior (HP:0030082) | 2.19657725 |
| 59 | Polydipsia (HP:0001959) | 2.19657725 |
| 60 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.14457115 |
| 61 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.14457115 |
| 62 | Hemiparesis (HP:0001269) | 2.12447306 |
| 63 | Retinal dysplasia (HP:0007973) | 2.12309254 |
| 64 | Increased serum lactate (HP:0002151) | 2.11747542 |
| 65 | Hypothermia (HP:0002045) | 2.07857132 |
| 66 | Poor coordination (HP:0002370) | 2.07509087 |
| 67 | Drooling (HP:0002307) | 2.06070916 |
| 68 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.06030935 |
| 69 | Abnormality of glycine metabolism (HP:0010895) | 2.06030935 |
| 70 | Cerebral edema (HP:0002181) | 2.04073459 |
| 71 | Abnormal biliary tract physiology (HP:0012439) | 2.03955172 |
| 72 | Bile duct proliferation (HP:0001408) | 2.03955172 |
| 73 | Limb hypertonia (HP:0002509) | 2.03836689 |
| 74 | 3-Methylglutaconic aciduria (HP:0003535) | 2.03281873 |
| 75 | Congenital stationary night blindness (HP:0007642) | 15.2621918 |
| 76 | Bony spicule pigmentary retinopathy (HP:0007737) | 11.8077170 |
| 77 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 10.3000108 |
| 78 | Abnormal rod and cone electroretinograms (HP:0008323) | 10.1685519 |
| 79 | Abnormality of the metopic suture (HP:0005556) | 1.99202981 |
| 80 | Broad-based gait (HP:0002136) | 1.97990416 |
| 81 | Polyphagia (HP:0002591) | 1.94391238 |
| 82 | Polymicrogyria (HP:0002126) | 1.93276371 |
| 83 | Narrow forehead (HP:0000341) | 1.90752319 |
| 84 | Tubular atrophy (HP:0000092) | 1.90628132 |
| 85 | Disproportionate short-trunk short stature (HP:0003521) | 1.89915141 |
| 86 | Supernumerary spleens (HP:0009799) | 1.89344560 |
| 87 | Renal Fanconi syndrome (HP:0001994) | 1.88666935 |
| 88 | Enlarged kidneys (HP:0000105) | 1.88209904 |
| 89 | Progressive microcephaly (HP:0000253) | 1.87805165 |
| 90 | Vaginal atresia (HP:0000148) | 1.86091959 |
| 91 | Lactic acidosis (HP:0003128) | 1.85047740 |
| 92 | True hermaphroditism (HP:0010459) | 1.83838688 |
| 93 | Occipital encephalocele (HP:0002085) | 1.83400482 |
| 94 | Gaze-evoked nystagmus (HP:0000640) | 1.82307065 |
| 95 | Excessive salivation (HP:0003781) | 1.81649834 |
| 96 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.80697512 |
| 97 | Amblyopia (HP:0000646) | 1.79269637 |
| 98 | Genital tract atresia (HP:0001827) | 1.78783604 |
| 99 | Male pseudohermaphroditism (HP:0000037) | 1.78383747 |
| 100 | Increased hepatocellular lipid droplets (HP:0006565) | 1.77913526 |
| 101 | Agitation (HP:0000713) | 1.77352079 |
| 102 | Polyuria (HP:0000103) | 1.75891454 |
| 103 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.75854246 |
| 104 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.75854246 |
| 105 | Abnormal protein glycosylation (HP:0012346) | 1.75854246 |
| 106 | Abnormal glycosylation (HP:0012345) | 1.75854246 |
| 107 | Adrenal hypoplasia (HP:0000835) | 1.74314176 |
| 108 | Lipid accumulation in hepatocytes (HP:0006561) | 1.73925420 |
| 109 | Asplenia (HP:0001746) | 1.73630448 |
| 110 | Optic atrophy (HP:0000648) | 1.69033172 |
| 111 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.58821747 |
| 112 | Pancreatic fibrosis (HP:0100732) | 1.51321844 |
| 113 | Hypoplasia of the fovea (HP:0007750) | 1.50169580 |
| 114 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.50169580 |
| 115 | Interstitial pulmonary disease (HP:0006530) | 1.45170495 |
| 116 | Horizontal nystagmus (HP:0000666) | 1.43874189 |
| 117 | Abnormality of the fovea (HP:0000493) | 1.42439287 |
| 118 | Polar cataract (HP:0010696) | 1.41296703 |
| 119 | Febrile seizures (HP:0002373) | 1.34628464 |
| 120 | Astigmatism (HP:0000483) | 1.32438703 |
| 121 | Severe Myopia (HP:0011003) | 1.25407534 |
| 122 | Epileptic encephalopathy (HP:0200134) | 1.25394606 |
| 123 | Pancreatic cysts (HP:0001737) | 1.20259353 |
| 124 | Broad foot (HP:0001769) | 1.19501230 |
| 125 | Cystic liver disease (HP:0006706) | 1.18034485 |
| 126 | Dysdiadochokinesis (HP:0002075) | 1.16569542 |
| 127 | Retinal detachment (HP:0000541) | 1.16169679 |
| 128 | Abnormality of midbrain morphology (HP:0002418) | 1.12553183 |
| 129 | Molar tooth sign on MRI (HP:0002419) | 1.12553183 |
| 130 | Specific learning disability (HP:0001328) | 1.08535608 |
| 131 | Left ventricular hypertrophy (HP:0001712) | 1.06285139 |
| 132 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.06115083 |
| 133 | Cerebellar dysplasia (HP:0007033) | 1.05974565 |
| 134 | Recurrent sinusitis (HP:0011108) | 1.03924810 |
| 135 | Chorioretinal coloboma (HP:0000567) | 1.03692698 |
| 136 | Decreased testicular size (HP:0008734) | 1.01638140 |
| 137 | Asthma (HP:0002099) | 0.98824885 |
| 138 | Chronic hepatic failure (HP:0100626) | 0.98791269 |
| 139 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 0.94938441 |
| 140 | Abnormality of dental color (HP:0011073) | 0.92023728 |
| 141 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 0.91555079 |
| 142 | Nephronophthisis (HP:0000090) | 0.91318561 |
| 143 | Sclerocornea (HP:0000647) | 0.89564953 |
| 144 | Congenital hepatic fibrosis (HP:0002612) | 0.87093577 |
| 145 | Progressive cerebellar ataxia (HP:0002073) | 0.86145610 |
| 146 | Postaxial hand polydactyly (HP:0001162) | 0.85664634 |
| 147 | Abnormality of the renal medulla (HP:0100957) | 0.81730096 |
| 148 | Hypermetropia (HP:0000540) | 0.81219803 |
| 149 | Truncal ataxia (HP:0002078) | 0.80804987 |
| 150 | Osteomalacia (HP:0002749) | 0.79906894 |
| 151 | Anencephaly (HP:0002323) | 0.77484887 |
| 152 | Dental crowding (HP:0000678) | 0.77145633 |
| 153 | Short foot (HP:0001773) | 0.76486318 |
| 154 | Lymphopenia (HP:0001888) | 0.75526197 |
| 155 | Furrowed tongue (HP:0000221) | 0.75379715 |
| 156 | Postaxial foot polydactyly (HP:0001830) | 0.75368521 |
| 157 | Abnormality of the fingertips (HP:0001211) | 0.71221473 |
| 158 | Hypodontia (HP:0000668) | 0.71019223 |
| 159 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 0.69479930 |
| 160 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 0.67681919 |
| 161 | Septo-optic dysplasia (HP:0100842) | 0.67057472 |
| 162 | Albinism (HP:0001022) | 0.65518043 |
| 163 | Nephrotic syndrome (HP:0000100) | 0.63760329 |
| 164 | Multicystic kidney dysplasia (HP:0000003) | 0.63299961 |
| 165 | Preaxial hand polydactyly (HP:0001177) | 0.63015403 |
| 166 | Hirsutism (HP:0001007) | 0.62871744 |
| 167 | Prolonged QT interval (HP:0001657) | 0.61451501 |
| 168 | Partial agenesis of the corpus callosum (HP:0001338) | 0.61302716 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GRK1 | 9.75676749 |
| 2 | PBK | 7.23088910 |
| 3 | MAP4K2 | 4.75810183 |
| 4 | WNK3 | 3.93497263 |
| 5 | IRAK2 | 2.91625078 |
| 6 | PINK1 | 2.87232017 |
| 7 | ADRBK2 | 2.28529346 |
| 8 | INSRR | 2.20344044 |
| 9 | WNK4 | 1.96543374 |
| 10 | BCKDK | 1.95036973 |
| 11 | PRPF4B | 1.90572719 |
| 12 | TRIM28 | 1.89645418 |
| 13 | CCNB1 | 1.81295570 |
| 14 | DYRK2 | 1.80014442 |
| 15 | AKT3 | 1.75367864 |
| 16 | BCR | 1.68369041 |
| 17 | MAPK7 | 1.66693625 |
| 18 | TAOK3 | 1.63308425 |
| 19 | SGK2 | 1.58901518 |
| 20 | ADRBK1 | 1.58752357 |
| 21 | SGK223 | 1.57702981 |
| 22 | SGK494 | 1.57702981 |
| 23 | CASK | 1.50787082 |
| 24 | STK16 | 1.46774589 |
| 25 | PAK3 | 1.41374184 |
| 26 | MAPK12 | 1.28476315 |
| 27 | CAMK1G | 1.26163089 |
| 28 | SIK2 | 1.25519774 |
| 29 | CDK3 | 1.24022154 |
| 30 | EPHA4 | 1.23287777 |
| 31 | MAP3K7 | 1.23089137 |
| 32 | CSNK1G3 | 1.18967140 |
| 33 | SGK3 | 1.18612240 |
| 34 | CSNK1G2 | 1.18497422 |
| 35 | RPS6KA4 | 1.14655762 |
| 36 | CDK12 | 1.13015703 |
| 37 | STK39 | 1.12935379 |
| 38 | TLK1 | 1.12140512 |
| 39 | MARK1 | 1.11435744 |
| 40 | OXSR1 | 1.08894643 |
| 41 | CSNK1G1 | 1.06765945 |
| 42 | NEK6 | 1.06515520 |
| 43 | YES1 | 1.06002155 |
| 44 | CSNK1A1L | 1.01547373 |
| 45 | TIE1 | 1.00813954 |
| 46 | PRKCZ | 0.99400639 |
| 47 | LATS1 | 0.99026475 |
| 48 | HIPK2 | 0.98895602 |
| 49 | MKNK2 | 0.96985928 |
| 50 | PRKCH | 0.95961084 |
| 51 | NTRK2 | 0.95516258 |
| 52 | BRD4 | 0.93320576 |
| 53 | ZAK | 0.91768158 |
| 54 | MAP2K7 | 0.90541618 |
| 55 | FGFR2 | 0.88454942 |
| 56 | PNCK | 0.84004868 |
| 57 | PRKD3 | 0.80070852 |
| 58 | CSNK1D | 0.77608312 |
| 59 | DAPK2 | 0.77444949 |
| 60 | CAMK1D | 0.77338378 |
| 61 | VRK1 | 0.74016151 |
| 62 | STK38 | 0.73474640 |
| 63 | TTK | 0.73248183 |
| 64 | EIF2AK3 | 0.72599313 |
| 65 | LIMK1 | 0.72593325 |
| 66 | FRK | 0.72587569 |
| 67 | MAPK13 | 0.72207857 |
| 68 | TNK2 | 0.70526241 |
| 69 | NUAK1 | 0.68993123 |
| 70 | DYRK1A | 0.68555775 |
| 71 | MAP3K4 | 0.68434205 |
| 72 | BMPR1B | 0.65906234 |
| 73 | TNIK | 0.64500116 |
| 74 | MST4 | 0.64213523 |
| 75 | MINK1 | 0.63306368 |
| 76 | PRKAA1 | 0.62702618 |
| 77 | EPHA3 | 0.62152330 |
| 78 | PTK2B | 0.60694888 |
| 79 | PRKCB | 0.59247469 |
| 80 | VRK2 | 0.59198323 |
| 81 | EPHB2 | 0.59125120 |
| 82 | IRAK1 | 0.57539466 |
| 83 | SRPK1 | 0.56466684 |
| 84 | PRKACG | 0.56278563 |
| 85 | FES | 0.56216169 |
| 86 | CDK9 | 0.56070774 |
| 87 | EIF2AK1 | 0.55786412 |
| 88 | PRKAA2 | 0.55692642 |
| 89 | CAMKK2 | 0.55589228 |
| 90 | FLT3 | 0.54872908 |
| 91 | MYLK | 0.54422829 |
| 92 | ERBB3 | 0.54174350 |
| 93 | CHUK | 0.53593730 |
| 94 | SGK1 | 0.53260653 |
| 95 | MAP3K10 | 0.52520679 |
| 96 | CAMK2D | 0.52471141 |
| 97 | RPS6KB1 | 0.52208615 |
| 98 | PLK2 | 0.52166287 |
| 99 | WNK1 | 0.51270330 |
| 100 | ERBB2 | 0.49036848 |
| 101 | CAMK1 | 0.47487249 |
| 102 | PLK3 | 0.47371858 |
| 103 | CDK5 | 0.46502083 |
| 104 | CSNK1A1 | 0.46039099 |
| 105 | PRKD2 | 0.45648134 |
| 106 | RPS6KA3 | 0.45298552 |
| 107 | PRKCQ | 0.45256401 |
| 108 | BMPR2 | 0.44303652 |
| 109 | PHKG2 | 0.44115181 |
| 110 | PHKG1 | 0.44115181 |
| 111 | GRK7 | 0.43458547 |
| 112 | MUSK | 0.43039203 |
| 113 | SIK3 | 0.42841564 |
| 114 | DYRK3 | 0.42818171 |
| 115 | MAPK14 | 0.42705984 |
| 116 | ICK | 0.42645947 |
| 117 | CAMK2A | 0.42035243 |
| 118 | MAP3K14 | 0.41813575 |
| 119 | RPS6KA5 | 0.41787233 |
| 120 | GRK5 | 0.41552323 |
| 121 | KDR | 0.40870876 |
| 122 | GSK3B | 0.40316430 |
| 123 | CDK19 | 0.38232509 |
| 124 | TXK | 0.37746773 |
| 125 | PRKDC | 0.37404485 |
| 126 | PRKCG | 0.37119143 |
| 127 | PAK6 | 0.36989891 |
| 128 | NTRK3 | 0.36380352 |
| 129 | PRKACA | 0.36187976 |
| 130 | FER | 0.36095199 |
| 131 | MAP2K6 | 0.34881365 |
| 132 | PRKCA | 0.34299413 |
| 133 | CAMK4 | 0.33852954 |
| 134 | MAP3K13 | 0.33846208 |
| 135 | MKNK1 | 0.33540748 |
| 136 | PRKCI | 0.33430637 |
| 137 | ACVR1B | 0.32904187 |
| 138 | AKT2 | 0.32138042 |
| 139 | CHEK2 | 0.31794307 |
| 140 | PIK3CA | 0.31372867 |
| 141 | PKN1 | 0.30952171 |
| 142 | ATM | 0.30713892 |
| 143 | STK38L | 0.30696328 |
| 144 | JAK1 | 0.30273396 |
| 145 | MAPK9 | 0.30257452 |
| 146 | ROCK1 | 0.30021606 |
| 147 | TEC | 0.29471389 |
| 148 | EIF2AK2 | 0.29427104 |
| 149 | ATR | 0.28622445 |
| 150 | CAMKK1 | 0.28567713 |
| 151 | NEK2 | 0.28237382 |
| 152 | CDK1 | 0.27844542 |
| 153 | PRKCE | 0.27002156 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 3.05316107 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.89550637 |
| 3 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.87375950 |
| 4 | Protein export_Homo sapiens_hsa03060 | 2.50811810 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.46712603 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.09654180 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.07709367 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 2.03688214 |
| 9 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.02876228 |
| 10 | Phototransduction_Homo sapiens_hsa04744 | 16.2025957 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.85538612 |
| 12 | Parkinsons disease_Homo sapiens_hsa05012 | 1.85260386 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 1.49029916 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 1.45137553 |
| 15 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.42414472 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.37735633 |
| 17 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.36046944 |
| 18 | Huntingtons disease_Homo sapiens_hsa05016 | 1.34597795 |
| 19 | Basal transcription factors_Homo sapiens_hsa03022 | 1.33189354 |
| 20 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.32487548 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.30855539 |
| 22 | Alzheimers disease_Homo sapiens_hsa05010 | 1.27328603 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.26066737 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.24579309 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.22635058 |
| 26 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.19803595 |
| 27 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.17858082 |
| 28 | Proteasome_Homo sapiens_hsa03050 | 1.14317938 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.08934306 |
| 30 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.07124054 |
| 31 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.03701712 |
| 32 | GABAergic synapse_Homo sapiens_hsa04727 | 1.02188623 |
| 33 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.99158445 |
| 34 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.98188210 |
| 35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.97613668 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.97581131 |
| 37 | Retinol metabolism_Homo sapiens_hsa00830 | 0.96424104 |
| 38 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.94449572 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.94236201 |
| 40 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.91155968 |
| 41 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.90895330 |
| 42 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.90877671 |
| 43 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.88362453 |
| 44 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.87774586 |
| 45 | Metabolic pathways_Homo sapiens_hsa01100 | 0.84283097 |
| 46 | Homologous recombination_Homo sapiens_hsa03440 | 0.82359267 |
| 47 | Circadian rhythm_Homo sapiens_hsa04710 | 0.82240037 |
| 48 | Morphine addiction_Homo sapiens_hsa05032 | 0.80377980 |
| 49 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.79015386 |
| 50 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.78668777 |
| 51 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.76983349 |
| 52 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.76659280 |
| 53 | Circadian entrainment_Homo sapiens_hsa04713 | 0.70023065 |
| 54 | Base excision repair_Homo sapiens_hsa03410 | 0.68625212 |
| 55 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.68257466 |
| 56 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.67069020 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 0.66940417 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.66858273 |
| 59 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.66533660 |
| 60 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.63924082 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62071937 |
| 62 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61974384 |
| 63 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.61589279 |
| 64 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.59934301 |
| 65 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.58368611 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.56499365 |
| 67 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.54628395 |
| 68 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.52830619 |
| 69 | Purine metabolism_Homo sapiens_hsa00230 | 0.51968475 |
| 70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.51678470 |
| 71 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49683076 |
| 72 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.49137562 |
| 73 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.48478690 |
| 74 | Insulin secretion_Homo sapiens_hsa04911 | 0.48207139 |
| 75 | Nicotine addiction_Homo sapiens_hsa05033 | 0.47607427 |
| 76 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.42547002 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42199372 |
| 78 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.41743083 |
| 79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.38209018 |
| 80 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.35127136 |
| 81 | Sulfur relay system_Homo sapiens_hsa04122 | 0.34873395 |
| 82 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.34187732 |
| 83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33479676 |
| 84 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.32292324 |
| 85 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.31412282 |
| 86 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.30823753 |
| 87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.30183414 |
| 88 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.28086228 |
| 89 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.26697073 |
| 90 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.26488374 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.25136931 |
| 92 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.23873907 |
| 93 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.22483742 |
| 94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.21556649 |
| 95 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.20392109 |
| 96 | Cocaine addiction_Homo sapiens_hsa05030 | 0.20350271 |
| 97 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.20305624 |
| 98 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.20015437 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.19338893 |
| 100 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.19057113 |
| 101 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.19053888 |
| 102 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.18666451 |
| 103 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.18613362 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17205951 |
| 105 | Lysine degradation_Homo sapiens_hsa00310 | 0.17027215 |
| 106 | Renin secretion_Homo sapiens_hsa04924 | 0.16968472 |
| 107 | Salivary secretion_Homo sapiens_hsa04970 | 0.16641394 |
| 108 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.16311035 |
| 109 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.16035916 |
| 110 | Taste transduction_Homo sapiens_hsa04742 | 0.16013878 |
| 111 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.15884222 |
| 112 | Alcoholism_Homo sapiens_hsa05034 | 0.15737314 |
| 113 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.15371532 |
| 114 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14592724 |
| 115 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.14425234 |
| 116 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.14183740 |
| 117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.13750708 |
| 118 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.12544826 |
| 119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.11565112 |
| 120 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.11034576 |
| 121 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.10727830 |
| 122 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.10331083 |
| 123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.10094841 |
| 124 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.09672270 |
| 125 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.09360928 |
| 126 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.09153845 |
| 127 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.08549168 |
| 128 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.08421156 |
| 129 | RNA degradation_Homo sapiens_hsa03018 | 0.08392222 |
| 130 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.08272003 |
| 131 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.08165529 |
| 132 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.07994727 |
| 133 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07614272 |
| 134 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.07109999 |
| 135 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.06814693 |
| 136 | Mineral absorption_Homo sapiens_hsa04978 | 0.06730380 |
| 137 | Long-term potentiation_Homo sapiens_hsa04720 | 0.06584112 |
| 138 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.06577357 |
| 139 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.06530449 |
| 140 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.06038893 |
| 141 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.05983789 |
| 142 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.05702352 |
| 143 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.05178424 |
| 144 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.05116745 |
| 145 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.05092553 |
| 146 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04860431 |
| 147 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.04202351 |
| 148 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.04082653 |
| 149 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.03826952 |
| 150 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.03658463 |
| 151 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.02635884 |
| 152 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.01951613 |
| 153 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.01655933 |
| 154 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.01464828 |
| 155 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.01063056 |
| 156 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.00830992 |
| 157 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.00744458 |
| 158 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.00555357 |

